These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31818649)

  • 1. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014.
    Tabakin AL; Shinder BM; Kim S; Rivera-Nunez Z; Polotti CF; Modi PK; Sterling JA; Farber NJ; Radadia KD; Parikh RR; Kim IY; Saraiya B; Mayer TM; Singer EA; Jang TL
    Clin Genitourin Cancer; 2020 Apr; 18(2):e194-e201. PubMed ID: 31818649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroperitoneal lymph node dissection for testicular seminomas: population-based practice and survival outcomes.
    Patel HD; Joice GA; Schwen ZR; Semerjian A; Alam R; Srivastava A; Allaf ME; Pierorazio PM
    World J Urol; 2018 Jan; 36(1):73-78. PubMed ID: 29026972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retroperitoneal Lymph Node Dissection as First-Line Treatment of Node-Positive Seminoma.
    Hu B; Shah S; Shojaei S; Daneshmand S
    Clin Genitourin Cancer; 2015 Aug; 13(4):e265-e269. PubMed ID: 25682512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes.
    Woldu SL; Moore JA; Ci B; Freifeld Y; Clinton TN; Aydin AM; Singla N; Laura-Maria K; Hutchinson RC; Amatruda JF; Sagalowsky A; Lotan Y; Arriaga Y; Margulis V; Xie Y; Bagrodia A
    Eur Urol Oncol; 2018 Aug; 1(3):242-251. PubMed ID: 31058267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current controversies on the role of retroperitoneal lymphadenectomy for testicular cancer.
    Mano R; Di Natale R; Sheinfeld J
    Urol Oncol; 2019 Mar; 37(3):209-218. PubMed ID: 30446455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
    Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer: current status.
    Bhayani SB; Allaf ME; Kavoussi LR
    Urol Oncol; 2004; 22(2):145-8. PubMed ID: 15082014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy.
    Tachibana I; Alabd A; Whaley RD; McFadden J; Piroozi A; Hassoun R; Kern SQ; King J; Adra N; Rice KR; Foster RS; Einhorn LH; Cary C; Masterson TA
    Urol Oncol; 2023 Sep; 41(9):394.e1-394.e6. PubMed ID: 37543446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?
    Tachibana I; Alabd A; Tong Y; Piroozi A; Mahmoud M; Kern SQ; Masterson TA; Adra N; Foster RS; Hanna NH; Einhorn LH; Cary C
    J Clin Oncol; 2023 Aug; 41(23):3930-3938. PubMed ID: 36730902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy.
    Mazzone E; Mistretta FA; Knipper S; Tian Z; Palumbo C; Gandaglia G; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Dec; 17(6):e1153-e1162. PubMed ID: 31515197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: a long-term update.
    Bhayani SB; Ong A; Oh WK; Kantoff PW; Kavoussi LR
    Urology; 2003 Aug; 62(2):324-7. PubMed ID: 12893344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propensity-matched Analysis of Open Versus Robotic Primary Retroperitoneal Lymph Node Dissection for Clinical Stage II Testicular Cancer.
    Chavarriaga J; Atenafu EG; Mousa A; Langleben C; Anson-Cartwright L; Jewett M; Hamilton RJ
    Eur Urol Oncol; 2024 Oct; 7(5):1034-1041. PubMed ID: 38278693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-chemotherapy retroperitoneal lymph node dissection in the management of metastatic testis cancer: the 16-year experience in an Irish setting.
    Considine S; Heaney R; Conroy R; Thornhill JA
    Ir J Med Sci; 2016 Nov; 185(4):901-907. PubMed ID: 26692387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy.
    Daneshmand S; Cary C; Masterson T; Einhorn L; Adra N; Boorjian SA; Kollmannsberger C; Schuckman A; So A; Black P; Bagrodia A; Skinner E; Alemozaffar M; Brand T; Eggener S; Pierorazio P; Stratton K; Nappi L; Nichols C; Luo C; Li M; Hu B
    J Clin Oncol; 2023 Jun; 41(16):3009-3018. PubMed ID: 36913642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.
    Syan-Bhanvadia S; Bazargani ST; Clifford TG; Cai J; Miranda G; Daneshmand S
    Eur Urol; 2017 Nov; 72(5):814-820. PubMed ID: 28325537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Recurrence for Clinical Stage I and II Patients With Teratoma Only at Primary Retroperitoneal Lymph Node Dissection.
    Liu NW; Cary C; Strine AC; Beck SD; Masterson TA; Bihrle R; Foster RS
    Urology; 2015 Nov; 86(5):981-4. PubMed ID: 26232690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of a population based sample of men diagnosed with testicular cancer in the United States.
    Osswald M; Harlan LC; Penson D; Stevens JL; Clegg LX
    Urol Oncol; 2009; 27(6):604-10. PubMed ID: 18799329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
    BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen.
    Dowling CM; Assel M; Musser JE; Meeks JJ; Sjoberg DD; Bosl G; Motzer R; Bajorin D; Feldman D; Carver BS; Sheinfeld J
    Urology; 2018 Apr; 114():133-138. PubMed ID: 29410311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.